The hypothesis, “claudin-1-mediated tight junction dysfunction contributes to atopic march”, is mainly supported by three lines of evidence: clinical observations, animal models of allergic diseases, and CLDN-1 knockdown studies. Here, CLDN1 is linked to allergic disease.